Structure and function of HIV-1 integrase

Current Topics in Medicinal Chemistry

Volumn 4, Issue 9, 2004, Pages 965-979

  Chiu, Thang K ^a   Davies, David R ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 CHLOROINDOLE 3 YL) 3 HYDROXY 3(2H TETRAZOL 5 YL) PROPENONE; 1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 4 ACETYLAMINO 5 HYDROXYNAPHTHALENE 2,7 DISULFONIC ACID; CYSTEINE; DIHYDROXYPHENYLTETRAPHENYLARSONSIUM; DISTAMYCIN A; DNA FRAGMENT; HISTONE; INTEGRASE; INTEGRASE INHIBITOR; OLIGONUCLEOTIDE; POLYAMIDE; PROTEINASE; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS DNA; ZINC; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CROSS LINKING REAGENT;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; DNA BINDING; DRUG DESIGN; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITOR INTERACTION; ENZYME STRUCTURE; METAL BINDING; NONHUMAN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MOTIF; REVIEW; SRC HOMOLOGY DOMAIN; VIRUS DNA CELL DNA INTERACTION; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; X RAY CRYSTALLOGRAPHY;

ANTI-HIV AGENTS; BINDING SITES; CROSS-LINKING REAGENTS; CRYSTALLOGRAPHY, X-RAY; DNA, VIRAL; HIV INTEGRASE; HIV INTEGRASE INHIBITORS; HIV-1; HUMANS; MODELS, MOLECULAR;

EID: 2942553781     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026043388547     Document Type: Review

References (114)

1. Brown, P. O. In Retroviruses; Coffin, J. M.; Hughes, S. H.; Varmus, H. E.; Eds.; Cold Spring Harbor Laboratory, 1997; pp 161-203.
2. Craigie, R. HIV integrase, a brief overview from chemistry to therapeutics. Journal of Biological Chemistry 2001, 276, 23213-23216.
3. Asante-Appiah, E.; Skalka, A. M. Molecular mechanisms in retrovirus DNA integration. Antiviral Research 1997, 36, 139-156.
4. Hindmarsh, P.; Leis, J. Retroviral DNA integration. Microbiology and Molecular Biology Reviews 1999, 63, 836-843.
5. Mumm, S. R.; Grandgenett, D. P. Defining Nucleic Acid-Binding Properties of Avian Retrovirus Integrase by Deletion Analysis. Journal of Virology 1991, 65, 1160-1167.
6. Engelman, A.; Craigie, R. Identification of Conserved Amino-Acid-Residues Critical for Human-Immunodeficiency-Virus Type-1 Integrase Function-Invitro. Journal of Virology 1992, 66, 6361-6369.
7. Vangent, D. C.; Groeneger, A. M. O.; Plasterk, R. H. A. Identification of Amino-Acids in Hiv-2 Integrase Involved in Site-Specific Hydrolysis and Alcoholysis of Viral-DNA Termini. Nucleic Acids Research 1993, 21, 3373-3377.
8. Katzman, M.; Sudol, M. Mapping Domains of Retroviral Integrase Responsible for Viral- DNA Specificity and Target Site Selection by Analysis of Chimeras between Human-Immunodeficiency-Virus Type-1 and Visna Virus Integrases. Journal of Virology 1995, 69, 5687-5696.
9. Dyda, F.; Hickman, A. B.; Jenkins, T. M.; Engelman, A.; Craigie, R.; Davies, D. R. Crystal-Structure of the Catalytic Domain of Hiv-1 Integrase - Similarity to Other Polynucleotidyl Transferases. Science 1994, 266, 1981-1986.
10. Goldgur, Y.; Dyda, F.; Hickman, A. B.; Jenkins, T. M.; Craigie, R.; Davies, D. R. Three new structures of the core domain of HIV-1 integrase: An active site that binds magnesium. Proceedings of the National Academy of Sciences of the United States of America 1998, 95, 9150-9154.
11. Greenwald, J.; Le, V.; Butler, S. L.; Bushman, F. D.; Choe, S. The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity. Biochemistry 1999, 38, 8892-8898.
12. Maignan, S.; Guilloteau, J. P.; Zhou-Liu, Q.; Clement-Mella, C.; Mikol, V. Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: High level of similarity of the active site with other viral integrases. Journal of Molecular Biology 1998, 282, 359-368.
13. Bujacz, G.; Jaskoski, M.; Alexandratos, J.; Wlodawer, A.; Merkel, G.; Katz, R. A.; Skalka, A. M. High-Resolution Structure of the Catalytic Domain of Avian- Sarcoma Virus Integrase. Journal of Molecular Biology 1995, 253, 333-346.
14. Bujacz, G.; Jaskolski, M.; Alexandratos, J.; Wlodawer, A.; Merkel, G.; Katz, R. A.; Skalka, A. M. The catalytic domain of avian sarcoma virus integrase: Conformation of the active-site residues in the presence of divalent cations. Structure 1996, 4, 89-96.
15. Bujacz, G.; Alexandratos, J.; ZhouLiu, Q.; ClementMella, C.; Wlodawer, A. The catalytic domain of human immunodeficiency virus integrase: Ordered active site in the F185H mutant. Febs Letters 1996, 398, 175-178.
16. Bujacz, G.; Alexandratos, J.; Wlodawer, A. Binding of different divalent cations to the active site of avian sarcoma virus integrase and their effects on enzymatic activity. Journal of Biological Chemistry 1997, 272, 18161-18168.
17. Lubkowski, J.; Yang, F.; Alexandratos, J.; Merkel, G.; Katz, R. A.; Gravuer, K.; Skalka, A. M.; Wlodawer, A. Structural basis for inactivating mutations and pH-dependent activity of avian sarcoma virus integrase. Journal of Biological Chemistry 1998, 273, 32685-32689.
18. Lubkowski, J.; Dauter, Z.; Yang, F.; Alexandratos, J.; Merkel, G.; Skalka, A. M.; Wlodawer, A. Atomic resolution structures of the core domain of avian sarcoma virus integrase and its D64N mutant (vol 38, pg 13512, 1999). Biochemistry 1999, 38, 15060-15060.
19. Lodi, P. J.; Ernst, J. A.; Kuszewski, J.; Hickman, A. B.; Engelman, A.; Craigie, R.; Clore, G. M.; Gronenborn, A. M. Solution Structure of the DNA-Binding Domain of Hiv-1 Integrase. Biochemistry 1995, 34, 9826-9833.
20. Eijkelenboom, A.; Sprangers, R.; Hard, K.; Lutzke, R. A. P.; Plasterk, R. H. A.; Boelens, R.; Kaptein, R. Refined solution structure of the C-terminal DNA-binding domain of human immunovirus-1 integrase. Proteins-Structure Function and Genetics 1999, 36, 556-564.
21. Cai, M. L.; Zheng, R. L.; Caffrey, M.; Craigie, R.; Clore, G. M.; Gronenborn, A. M. Solution structure of the N-terminal zinc binding domain of HIV-1 integrase. Nature Structural Biology 1997, 4, 567-577.
22. Cai, M, L.; Huang, Y.; Caffrey, M.; Zheng, R. L.; Craigie, R.; Clore, G. M.; Gronenborn, A. M. Solution structure of the His12 ? Cys mutant of the N-terminal zinc binding domain of HIV-1 integrase complexed to cadmium. Protein Science 1998, 7, 2669-2674.
23. Eijkelenboom, A.; vandenEnt, F. M. I.; Vos, A.; Doreleijers, J. F.; Hard, K.; Tullius, T. D.; Plasterk, R. H. A.; Kaptein, R.; Boelens, R. The solution structure of the amino-terminal HHCC domain of HIV-2 integrase: a three-helix bundle stabilized by zinc. Current Biology 1997, 7, 739-746.
24. Wang, J. Y.; Ling, H.; Yang, W.; Craigie, R. Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein. EMBO Journal 2001, 20, 7333-7343.
25. Chen, J. C. H.; Krucinski, J.; Miercke, L. J. W.; Finer-Moore, J. S.; Tang, A. H; Leavitt, A. D.; Stroud, R. M. Crystal structure of the HIV-1 integrase catalytic core and C- terminal domains: A model for viral DNA binding. Proceedings of the National Academy of Sciences of the United States of America 2000, 97, 8233-8238.
26. Chen, Z. G.; Yan, Y. W.; Munshi, S.; Li, Y.; Zugay-Murphy, J.; Xu, B.; Witmer, M.; Felock, P.; Wolfe, A.; Sardana, V.; Emini, E. A.; Hazuda, D.; Kuo, L. C. X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293) - An initial glance of the viral DNA binding platform. Journal of Molecular Biology 2000, 296, 521-533.
27. Yang, Z. N.; Mueser, T. C.; Bushman, F. D.; Hyde, C. C. Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase. Journal of Molecular Biology 2000, 296, 535-548.
28. Vangent, D. C.; Vink, C.; Groeneger, A.; Plasterk, R. H. A. Complementation between Hiv Integrase Proteins Mutated in Different Domains. EMBO Journal 1993, 12, 3261-3267.
29. Kulkosky, J.; Jones, K. S.; Katz, R. A.; Mack, J. P. G.; Skalka, A. M. Residues Critical for Retroviral Integrative Recombination in a Region That Is Highly Conserved among Retroviral Retrotransposon Integrases and Bacterial Insertion-Sequence Transposases. Molecular and Cellular Biology 1992, 12, 2331-2338.
30. Drelich, M.; Wilhelm, R.; Mous, J. Identification of Amino-Acid-Residues Critical for Endonuclease and Integration Activities of Hiv-1 in Protein Invitro. Virology 1992, 188, 459-468.
31. Bushman, F. D.; Engelman, A.; Palmer, I.; Wingfield, P.; Craigie, R. Domains of the Integrase Protein of Human-Immunodeficiency-Virus Type-1 Responsible for Polynucleotidyl Transfer and Zinc-Binding. Proceedings of the National Academy of Sciences of the United States of America 1993, 90, 3428-3432.
32. Mazumder, A.; Engelman, A.; Craigie, R.; Fesen, M.; Pommier, Y. Intermolecular Disintegration and Intramolecular Strand Transfer Activities of Wild-Type and Mutant Hiv-1 Integrase. Nucleic Acids Research 1994, 22, 1037-1043.
33. Jonsson, C. B.; Donzella, G. A.; Gaucan, E.; Smith, C. M.; Roth, M. J. Functional domains of moloney murine leukemia virus integrase defined by mutation and complementation analysis. Journal of Virology 1996, 70, 4585-4597.
34. Shibagaki, Y.; Holmes, M. L.; Appa, R. S.; Chow, S. A. Characterization of feline immunodeficiency virus integrase and analysis of functional domains. Virology 1997, 230, 1-10.
35. Vink, C.; Groeneger, A.; Plasterk, R. H. A. Identification of the Catalytic and DNA-Binding Region of the Human-Immunodeficiency-Virus Type-I Integrase Protein. Nucleic Acids Research 1993, 21, 1419-1425.
36. Schauer, M.; Billich, A. The N-Terminal Region of Hiv-1 Integrase Is Required for Integration Activity, but Not for DNA-Binding. Biochemical and Biophysical Research Communications 1992, 185, 874-880.
37. Kulkosky, J.; Katz, R. A.; Merkel, G.; Skalka, A. M. Activities and Substrate-Specificity of the Evolutionarily Conserved Central Domain of Retroviral Integrase. Virology 1995, 206, 448-456.
38. Engelman, A.; Bushman, F. D.; Craigie, R. Identification of Discrete Functional Domains of Hiv-1 Integrase and Their Organization within an Active Multimeric Complex. EMBO Journal 1993, 12, 3269-3275.
39. Katayanagi, K.; Okumura, M.; Morikawa, K. Crystal-Structure of Escherichia-Coli Rnase Hi in Complex with Mg2+ at 2.8 Angstrom Resolution - Proof for a Single Mg2+- Binding Site. Proteins-Structure Function and Genetics 1993, 17, 337-346.
40. Rice, P.; Mizuuchi, K. Structure of the Bacteriophage-Mu Transposase Core - a Common Structural Motif for DNA Transposition and Retroviral Integration. Cell 1995, 82, 209-220.
41. Ariyoshi, M.; Vassylyev, D. G.; Iwasaki, H.; Nakamura, H.; Shinagawa, H.; Morikawa, K. Atomic-Structure of the Ruvc Resolvase - a Holliday Junction- Specific Endonuclease from Escherichia-Coli. Cell 1994, 78, 1063-1072.
42. Jenkins, T. M.; Hickman, A. B.; Dyda, F.; Ghirlando, R.; Davies, D. R.; Craigie, R. Catalytic Domain of Human-Immunodeficiency-Virus Type-1 Integrase - Identification of a Soluble Mutant by Systematic Replacement of Hydrophobic Residues. Proceedings of the National Academy of Sciences of the United States of America 1995, 92, 6057-6061.
43. Jenkins, T. M.; Engelman, A.; Ghirlando, R.; Craigie, R. A soluble active mutant of HIV-1 integrase - Involvement of both the core and carboxyl-terminal domains in multimerization. Journal of Biological Chemistry 1996, 271, 7712-7718.
44. Engelman, A.; Liu, Y.; Chen, H. M.; Farzan, M.; Dyda, F. Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase. Journal of Virology 1997, 71, 3507-3514.
45. Molteni, V.; Greenwald, J.; Rhodes, D.; Hwang, Y.; Kwiatkowski, W.; Bushman, F. D.; Siegel, J. S.; Choe, S. Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain. Acta Crystallographica Section D-Biological Crystallography 2001, 57, 536-544.
46. Goldgur, Y.; Craigie, R.; Cohen, G. H.; Fujiwara, T.; Yoshinaga, T.; Fujishita, T.; Sugimoto, H.; Endo, T.; Murai, H.; Davies, D. R. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design. Proceedings of the National Academy of Sciences of the United States of America 1999, 96, 13040-13043.
47. Lubkowski, J.; Dauter, Z.; Yang, F.; Alexandratos, J.; Merkel, G.; Skalka, A. M.; Wlodawer, A. Atomic resolution structures of the core domain of avian sarcoma virus integrase and its D64N mutant. Biochemistry 1999, 38, 13512-13522.
48. Bushman, F. D.; Wang, B. B. Rous-Sarcoma Virus Integrase Protein - Mapping Functions for Catalysis and Substrate-Binding. Journal of Virology 1994, 68, 2215-2223.
49. Pahl, A.; Flugel, R. M. Characterization of the Human Spuma Retrovirus Integrase by Site-Directed Mutagenesis, by Complementation Analysis, and by Swapping the Zinc-Finger Domain of Hiv-1. Journal of Biological Chemistry 1995, 270, 2957-2966.
50. van Gent, D. C.; Vink, C.; Groeneger, A.; Plasterk, R. H. A. Complementation between Hiv Integrase Proteins Mutated in Different Domains. EMBO Journal 1993, 12, 3261-3267.
51. Zheng, R. L.; Jenkins, T. M.; Craigie, R. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proceedings of the National Academy of Sciences of the United States of America 1996, 93, 13659-13664.
52. Katz, R. A.; Merkel, G.; Skalka, A. M. Targeting of retroviral integrase by fusion to a heterologous DNA binding domain: In vitro activities and incorporation of a fusion protein into viral particles. Virology 1996, 217, 178-190.
53. Khan, E.; Mack, J. P. G.; Katz, R. A.; Kulkosky, J.; Skalka, A. M. Retroviral Integrase Domains - DNA-Binding and the Recognition of Ltr Sequences. Nucleic Acids Research 1991, 19, 851-860.
54. Lee, S. P.; Xiao, J. M.; Knutson, J. R.; Lewis, M. S.; Han, M. K. Zn2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro. Biochemistry 1997, 36, 173-180.
55. Hickman, A. B.; Palmer, I.; Engelman, A.; Craigie, R.; Wingfield, P. Biophysical and Enzymatic-Properties of the Catalytic Domain of Hiv-1 Integrase. Journal of Biological Chemistry 1994, 269, 29279-29287.
56. Ellison, V.; Brown, P. O. A Stable Complex between Integrase and Viral-DNA Ends Mediates Human-Immunodeficiency-Virus Integration in-Vitro. Proceedings of the National Academy of Sciences of the United States of the America 1994, 91, 7316-7320.
57. Goedken, E. R.; Keck, J. L.; Berger, J. M.; Marqusee, S. Divalent metal cofactor binding in the kinetic folding trajectory of Escherichia coli ribonuclease HI. Protein Science 2000, 9, 1914-1921.
58. Davies, J. F.; Hostomska, Z.; Hostomsky, Z.; Jordan, S. R.; Matthews, D. A. Crystal-Structure of the Ribonuclease-H Domain of Hiv-1 Reverse-Transcriptase. Science 1991, 252, 88-95.
59. Beese, L. S.; Steitz, T. A. Structural Basis for the 3′-5′ Exonuclease Activity of Escherichia-Coli DNA-Polymerase-I - a 2 Metal-Ion Mechanism. EMBO Journal 1991, 10, 25-33.
60. Neamati, N.; Turpin, J. A.; Winslow, H. E.; Christensen, J. L.; Williamson, K.; Orr, A.; Rice, W. G.; Pommier, Y.; Garofalo, A.; Brizzi, A.; Campiani, G.; Fiorini, I.; Nacci, V. Thiazolothiazepine inhibitors of HIV-1 integrase. Journal of Medicinal Chemistry 1999, 42, 3334-3341.
61. Pommier, Y.; Marchand, C.; Neamati, N. Retroviral integrase inhibitors year 2000: update and perspectives. Antiviral Research 2000, 47, 139-148.
62. Tarrago-Litvak, L.; Andreola, M. L.; Fournier, M.; Nevinsky, G. A.; Parissi, V.; de Soultrait, V. R.; Litvak, S. Inhibitors of HIV-1 reverse transcriptase and integrase: Classical and emerging therapeutical approaches. Current Pharmaceutical Design 2002, 8, 595-614.
63. Nair, V. HIV integrase as a target for antiviral chemotherapy. Reviews in Medical Virology 2002, 12, 179-193.
64. Clercq, E. D. New developments in anti-HIV chemotherapy. Biochimica et Biophysica Acta 2002, 1587, 258-275.
65. Grobler, J. A.; Stillmock, K.; Hu, B. H.; Witmer, M.; Felock, P.; Espeseth, A. S.; Wolfe, A.; Egbertson, M.; Bourgeois, M.; Melamed, J.; Wai, J. S.; Young, S.; Vacca, J.; Hazuda, D. J. Diketo acid inhibitor mechanism and HIV-1 integrase: Implications for metal binding in the active site of phosphotransferase enzymes. Proceedings of the National Academy of Sciences of the United States of America 2002, 99, 6661-6666.
66. Ryabinin, V. A.; Sinyakov, A. N.; de Soultrait, V. R.; Caumont, A.; Parissi, V.; Zakharova, O. D.; Vasyutina, E. L.; Yurchenko, E.; Bayandin, R.; Litvak, S.; Tarrago-Litvak, L.; Nevinsky, G. A. Inhibition of HIV-1 integrase-catalysed reaction by new DNA minor groove ligands: the oligo-1,3-thiazolecarboxamide derivatives. European Journal of Medicinal Chemistry 2000, 35, 989-1000.
67. Hazuda, D. J.; Felock, P.; Witmer, M.; Wolfe, A.; Stillmock, K.; Grobler, J. A.; Espeseth, A.; Gabryelski, L.; Schleif, W.; Blau, C.; Miller, M. D. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science 2000, 287, 646-650.
68. Espeseth, A. S.; Felock, P.; Wolfe, A.; Witmer, M.; Grobler, J.; Anthony, N.; Egbertson, M.; Melamed, J. Y.; Young, S.; Hamill, T.; Cole, J. L.; Hazuda, D. J. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase. Proceedings of the National Academy of Sciences of the United States of America 2000, 97, 11244-11249.
69. Jenkins, T. M.; Esposito, D.; Engelman, A.; Craigie, R. Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking. EMBO Journal 1997, 16, 6849-6859.
70. Esposito, D.; Craigie, R. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction. Embo Journal 1998, 17, 5832-5843.
71. Sotriffer, C. A.; Ni, H. H.; McCammon, J. A. HIV-1 integrase inhibitor interactions at the active site: Prediction of binding modes unaffected by crystal packing. Journal of the American Chemical Society 2000, 122, 6136-6137.
72. Melek, M.; Jones, J. M.; O'Dea, M. H.; Pais, G.; Burke, T. R.; Pommier, Y.; Neamati, N.; Gellert, M. Effect of HIV integrase inhibitors on the RAG1/2 recombinase. Proceedings of the National Academy of Sciences of the United States of America 2002, 99, 134-137.
73. Lubkowski, J.; Yang, F.; Alexandratos, J.; Wlodawer, A.; Zhao, H.; Burke, T. R.; Neamati, N.; Pommier, Y.; Merkel, G.; Skalka, A. M. Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor. Proceedings of the National Academy of Sciences of the United States of America 1998, 95, 4831-4836.
74. Caumont, A.; Jamieson, G.; de Soultrait, V. R.; Parissi, V.; Fournier, M.; Zakharova, O. D.; Bayandin, R.; Litvak, S.; Tarrago-Litvak, L.; Nevinsky, G. A. High affinity interaction of HIV-1 integrase with specific and non-specific single-stranded short oligonucleotides. FEBS Letters 1999, 455, 154-158.
75. Tramontano, E.; La Colla, P.; Cheng, Y. C. Biochemical characterization of the HIV-1 integrase 3′- processing activity and its inhibition by phosphorothioate oligonucleotides. Biochemistry 1998, 37, 7237-7243.
76. Snasel, J.; Rejman, D.; Liboska, R.; Tocik, Z.; Ruml, T.; Rosenberg, I.; Pichova, I. Inhibition of HIV-1 integrase by modified oligonucleotides derived from U5′ LTR. European Journal of Biochemistry 2001, 268, 980-986.
77. Taktakishvili, M.; Neamati, N.; Pommier, Y.; Nair, V. Recognition and inhibition of HIV integrase by a novel dinucleotide. Bioorganic & Medicinal Chemistry Letters 2000, 10, 249-251.
78. Kopka, M. L.; Yoon, C.; Goodsell, D.; Pjura, P.; Dickerson, R. E. The Molecular-Origin of DNA Drug Specificity in Netropsin and Distamycin. Proceedings of the National Academy of Sciences of the United States of America 1985, 82, 1376-1380.
79. Lown, J. W.; Krowicki, K.; Bhat, U. G.; Skorobogaty, A.; Ward, B.; Dabrowiak, J. C. Molecular Recognition between Oligopeptides and Nucleic-Acids - Novel Imidazole-Containing Oligopeptides Related to Netropsin That Exhibit Altered DNA-Sequence Specificity. Biochemistry 1986, 25, 7408-7416.
80. Chen, X.; Ramakrishnan, B.; Rao, S. T.; Sundaralingam, M. Binding of 2 Distamycin-a Molecules in the Minor-Groove of an Alternating B-DNA Duplex. Nature Structural Biology 1994, 1, 169-175.
81. Chen, Y. H.; Lown, J. W. A New DNA Minor-Groove Binding Motif - Cross-Linked Lexitropsins. Journal of the American Chemical Society 1994, 116, 6995-7005.
82. Mrksich, M.; Dervan, P. B. Antiparallel Side-by-Side Heterodimer for Sequence-Specific Recognition in the Minor Groove of DNA by a Distamycin 1- Methylimidazole-2-Carboxamide-Netropsin Pair. Journal of the American Chemical Society 1993, 115, 2572-2576.
83. Mrksich, M.; Dervan, P. B. Enhanced Sequence-Specific Recognition in the Minor-Groove of DNA by Covalent Peptide Dimers - Bis(Pyridine-2- Carboxamidonetropsin)(Ch2)3-6. Journal of the American Chemical Society 1993, 115, 9892-9899.
84. Kielkopf, C. L.; White, S.; Szewczyk, J. W.; Turner, J. M.; Baird, E. E.; Dervan, P. B.; Rees, D. C. A structural basis for recognition of A center dot T and T center dot A base pairs in the minor groove of B-DNA. Science 1998, 282, 111-115.
85. White, S.; Szewczyk, J. W.; Turner, J. M.; Baird, E. E.; Dervan, P. B. Recognition of the four Watson-Crick base pairs in the DNA minor groove by synthetic ligands. Nature 1998, 391, 468-471.
86. Goodsell, D.; Dickerson, R. E. Isohelical Analysis of DNA Groove-Binding Drugs. Journal of Medicinal Chemistry 1986, 29, 727-733.
87. Kelly, J. J.; Baird, E. E.; Dervan, P. B. Binding site size limit of the 2:1 pyrrole-imidazole polyamide- DNA motif. Proceedings of the National Academy of Sciences of the United States of America 1996, 93, 6981-6985.
88. Neamati, N.; Mazumder, A.; Sunder, S.; Owen, J. M.; Tandon, M.; Lown, J. W.; Pommier, Y. Highly potent synthetic polyamides, bisdistamycins, and lexitropsins as inhibitors of human immunodeficiency virus type 1 integrase. Molecular Pharmacology 1998, 54, 280-290.
89. Filipowsky, M. E.; Kopka, M. L.; BrazilZison, M.; Lown, J. W.; Dickerson, R. E. Linked lexitropsins and the in vitro inhibition of HIV-1 reverse transcriptase RNA-directed DNA polymerization: A novel induced-fit of 3,5 m-pyridyl bisdistamycin to enzyme-associated template-primer. Biochemistry 1996, 35, 15397-15410.
90. Mazumder, A.; Neamati, N.; Ojwang, J. O.; Sunder, S.; Rando, R. F.; Pommier, Y. Inhibition of the human immunodeficiency virus type I integrase by guanosine quartet structures. Biochemistry 1996, 35, 13762-13771.
91. Jing, N. J.; Marchand, C.; Liu, J.; Mitra, R.; Hogan, M. E.; Pommier, Y. Mechanism of inhibition of HIV-I integrase by G-tetrad-forming oligonucleotides in vitro. Journal of Biological Chemistry 2000, 275, 21460-21467.
92. Este, J. A.; Cabrera, C.; Schols, D.; Cherepanov, P.; Gutierrez, A.; Witvrouw, M.; Pannecouque, C.; Debyser, Z.; Rando, R. F.; Clotet, B.; Desmyter, J.; De Clercq, E. Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir). Molecular Pharmacology 1998, 53, 340-345.
93. Jing, N.; De Clercq, E.; Rando, R. F.; Pallansch, L.; Lackman-Smith, C.; Lee, S.; Hogan, M. E. Stability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors - A basis for anti-HIV drug design. Journal of Biological Chemistry 2000, 275, 3421-3430.
94. Heuer, T. S.; Brown, P. O. Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo-cross-linking. Biochemistry 1997, 36, 10655-10665.
95. Heuer, T. S.; Brown, P. O. Photo-cross-linking studies suggest a model for the architecture of an active human immunodeficiency virus type 1 integrase-DNA complex. Biochemistry 1998, 37, 6667-6678.
96. Lafemina, R. L.; Callahan, P. L.; Cordingley, M. G. Substrate-Specificity of Recombinant Human-Immunodeficiency- Virus Integrase Protein. Journal of Virology 1991, 65, 5624-5630.
97. Gao, K.; Butler, S. L.; Bushman, F. Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes. EMBO Journal 2001, 20, 3565-3576.
98. Bushman, F. D.; Craigie, R. Integration of Human-Immunodeficiency-Virus DNA - Adduct Interference Analysis of Required DNA Sites. Proceedings of the National Academy of Sciences of the United States of America 1992, 89, 3458-3462.
99. Yoshinaga, T.; Kimuraohtani, Y.; Fujiwara, T. Detection and Characterization of a Functional Complex of Human-Immunodeficiency-Virus Type-1 Integrase and Its DNA Substrate by Uv Cross-Linking. Journal of Virology 1994, 68, 5690-5697.
100. Mazumder, A.; Neamati, N.; Pilon, A. A.; Sunder, S.; Pommier, Y. Chemical trapping of ternary complexes of human immunodeficiency virus type I integrase, divalent metal, and DNA substrates containing an abasic site - Implications for the role of lysine 136 in DNA binding. Journal of Biological Chemistry 1996, 271, 27330-27338.
101. Gerton, J. L.; Brown, P. O. The core domain of HIV-1 integrase recognizes key features of its DNA substrates. Journal of Biological Chemistry 1997, 272, 25809-25815.
102. Vink, C.; Vangent, D. C.; Elgersma, Y.; Plasterk, R. H. A. Human-Immunodeficiency-Virus Integrase Protein Requires a Subterminal Position of Its Viral-DNA Recognition Sequence for Efficient Cleavage. Journal of Virology 1991, 65, 4636-4644.
103. Scottoline, B. P.; Chow, S.; Ellison, V.; Brown, P. O. Disruption of the terminal base pairs of retroviral DNA during integration. Genes & Development 1997, 11, 371-382.
104. Gerton, J. L.; Ohgi, S.; Olsen, M.; Derisi, J.; Brown, P. O. Effects of mutations in residues near the active site of human immunodeficiency virus type 1 integrase on specific enzyme-substrate interactions. Journal of Virology 1998, 72, 5046-5055.
105. Wang, T.; Balakrishnan, M.; Jonsson, C. B. Major and minor groove contacts in retroviral integrase-LTR interactions. Biochemistry 1999, 38, 3624-3632.
106. Ellison, V.; Gerton, J.; Vincent, K. A.; Brown, P. O. An Essential Interaction between Distinct Domains of Hiv-1 Integrase Mediates Assembly of the Active Multimer. Journal of Biological Chemistry 1995, 270, 3320-3326.
107. Vangent, D. C.; Elgersma, Y.; Bolk, M. W. J.; Vink, C.; Plasterk, R. H. A. DNA-Binding Properties of the Integrase Proteins of Human Immunodeficiency Viruses Type-1 and Type-2. Nucleic Acids Research 1991, 19, 3821-3827.
108. Engelman, A.; Hickman, A. B.; Craigie, R. The Core and Carboxyl-Terminal Domains of the Integrase Protein of Human-Immunodeficiency-Virus Type-1 Each Contribute to Nonspecific DNA-Binding. Journal of Virology 1994, 68, 5911-5917.
109. Pemberton, I. K.; Buckle, M.; Buc, H. The metal ion-induced cooperative binding of HIV-1 integrase to DNA exhibits a marked preference for Mn(II) rather than Mg(II). Journal of Biological Chemistry 1996, 271, 1498-1506.
110. Dirac, A. M. G.; Kjems, J. Mapping DNA-binding sites of HIV-1 integrase by protein footprinting. European Journal of Biochemistry 2001, 268, 743-751.
111. Davies, D. R.; Goryshin, I. Y.; Reznikoff, W. S.; Rayment, I. Three-dimensional structure of the Tn5 synaptic complex transposition intermediate. Science 2000, 289, 77-85.
112. Shibagaki, Y.; Chow, S. A. Central core domain of retroviral integrase is responsible for target site selection. Journal of Biological Chemistry 1997, 272, 8361-8369.
113. Kraulis, P. J. Molscript - a Program to Produce Both Detailed and Schematic Plots of Protein Structures. Journal of Applied Crystallography 1991, 24, 946-950.
114. Merritt, E. A.; Murphy, M. E. P. Raster3d Version-2.0 - a Program for Photorealistic Molecular Graphics. Acta Crystallographica Section D-Biological Crystallography 1994, 50, 869-873.